These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38031988)

  • 1. A State-of-the-Art Review on the Recent Advances of Mesenchymal Stem Cell Therapeutic Application in Systematic Lupus Erythematosus.
    Karimi F; Nejati B; Rahimi F; Alivirdiloo V; Alipourfard I; Aghighi A; Raji-Amirhasani A; Eslami M; Babaeizad A; Ghazi F; Firouzi Amandi A; Dadashpour M
    Immunol Invest; 2024 Feb; 53(2):160-184. PubMed ID: 38031988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lupus mice derived mesenchymal stromal cells: Beneficial or detrimental on SLE disease outcome.
    Hosseini S; Mahmoudi M; Rezaieyazdi Z; Shapouri-Moghaddam A; Hosseinzadeh A; Arab FL; Tabasi NS; Esmaeili SA
    Int Immunopharmacol; 2024 Jan; 126():111306. PubMed ID: 38039717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transplantation of mesenchymal stem cells ameliorates systemic lupus erythematosus and upregulates B10 cells through TGF-β1.
    Chun W; Tian J; Zhang Y
    Stem Cell Res Ther; 2021 Sep; 12(1):512. PubMed ID: 34563233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysregulated balance in Th17/Treg axis of Pristane-induced lupus mouse model, are mesenchymal stem cells therapeutic?
    Hoseinzadeh A; Rezaieyazdi Z; Mahmoudi M; Tavakol Afshari J; Lavi Arab F; Esmaeili SA; Faridzadeh A; Rezaeian A; Hoseini S; Barati M; Mahmoudi A; Sadat Tabasi N
    Int Immunopharmacol; 2023 Apr; 117():109699. PubMed ID: 36867923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of Mesenchymal Stem Cells-Mediated Adaptive Immune Effectors' Repertoire in the Recovery of Systemic Lupus Erythematosus.
    Hoseinzadeh A; Rezaieyazdi Z; Afshari JT; Mahmoudi A; Heydari S; Moradi R; Esmaeili SA; Mahmoudi M
    Stem Cell Rev Rep; 2023 Feb; 19(2):322-344. PubMed ID: 36272020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Applications of Mesenchymal Stem Cells for Systemic Lupus Erythematosus.
    Xu J
    Adv Exp Med Biol; 2018; 1089():73-85. PubMed ID: 29767288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Additive Therapeutic Effects of Mesenchymal Stem Cells and IL-37 for Systemic Lupus Erythematosus.
    Xu J; Chen J; Li W; Lian W; Huang J; Lai B; Li L; Huang Z
    J Am Soc Nephrol; 2020 Jan; 31(1):54-65. PubMed ID: 31604808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phorbol ester activates human mesenchymal stem cells to inhibit B cells and ameliorate lupus symptoms in MRL.
    Lee HK; Kim HS; Pyo M; Park EJ; Jang S; Jun HW; Lee TY; Kim KS; Bae SC; Kim Y; Hong JT; Yun J; Han SB
    Theranostics; 2020; 10(22):10186-10199. PubMed ID: 32929342
    [No Abstract]   [Full Text] [Related]  

  • 9. The immunomodulatory effects of mesenchymal stromal cell-based therapy in human and animal models of systemic lupus erythematosus.
    Radmanesh F; Mahmoudi M; Yazdanpanah E; Keyvani V; Kia N; Nikpoor AR; Zafari P; Esmaeili SA
    IUBMB Life; 2020 Nov; 72(11):2366-2381. PubMed ID: 33006813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multipotent Mesenchymal Stromal Cells in Rheumatoid Arthritis and Systemic Lupus Erythematosus; From a Leading Role in Pathogenesis to Potential Therapeutic Saviors?
    El-Jawhari JJ; El-Sherbiny Y; McGonagle D; Jones E
    Front Immunol; 2021; 12():643170. PubMed ID: 33732263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The regulation of the Treg/Th17 balance by mesenchymal stem cells in human systemic lupus erythematosus.
    Wang D; Huang S; Yuan X; Liang J; Xu R; Yao G; Feng X; Sun L
    Cell Mol Immunol; 2017 May; 14(5):423-431. PubMed ID: 26435067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal Stem Cells-derived Exosomes Ameliorate Lupus by Inducing M2 Macrophage Polarization and Regulatory T Cell Expansion in MRL/lpr Mice.
    Sun W; Yan S; Yang C; Yang J; Wang H; Li C; Zhang L; Zhao L; Zhang J; Cheng M; Li X; Xu D
    Immunol Invest; 2022 Aug; 51(6):1785-1803. PubMed ID: 35332841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematopoietic and mesenchymal stem cell transplantation for severe and refractory systemic lupus erythematosus.
    Sui W; Hou X; Che W; Chen J; Ou M; Xue W; Dai Y
    Clin Immunol; 2013 Aug; 148(2):186-97. PubMed ID: 23770628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional Characteristics and Application of Mesenchymal Stem Cells in Systemic Lupus Erythematosus.
    Tang WY; Liu JH; Peng CJ; Liao Y; Luo JS; Sun X; Tang YL; Luo XQ
    Arch Immunol Ther Exp (Warsz); 2021 Mar; 69(1):7. PubMed ID: 33713197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of human umbilical cord mesenchymal stem cells on inflammatory factors and miR-181a in T lymphocytes from patients with systemic lupus erythematosus.
    Zheng B; Zhang P; Yuan L; Chhetri RK; Guo Y; Deng D
    Lupus; 2020 Feb; 29(2):126-135. PubMed ID: 31870216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clearance of apoptotic cells by mesenchymal stem cells contributes to immunosuppression via PGE2.
    Zhang Z; Huang S; Wu S; Qi J; Li W; Liu S; Cong Y; Chen H; Lu L; Shi S; Wang D; Chen W; Sun L
    EBioMedicine; 2019 Jul; 45():341-350. PubMed ID: 31248835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin enhances the immunomodulatory potential of adipose-derived mesenchymal stem cells through STAT1 in an animal model of lupus.
    Jang SG; Lee J; Hong SM; Kwok SK; Cho ML; Park SH
    Rheumatology (Oxford); 2020 Jun; 59(6):1426-1438. PubMed ID: 31904843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal Stem Cell Therapy: Hope for Patients With Systemic Lupus Erythematosus.
    Li A; Guo F; Pan Q; Chen S; Chen J; Liu HF; Pan Q
    Front Immunol; 2021; 12():728190. PubMed ID: 34659214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospects for the Application of Transplantation With Human Amniotic Membrane Epithelial Stem Cells in Systemic Lupus Erythematosus.
    Xu L; Dai Q; Zhang Y; Lin N; Ji L; Song X
    Cell Transplant; 2024; 33():9636897241236586. PubMed ID: 38469823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-γ-dependent inhibition of B cell activation by bone marrow-derived mesenchymal stem cells in a murine model of systemic lupus erythematosus.
    Schena F; Gambini C; Gregorio A; Mosconi M; Reverberi D; Gattorno M; Casazza S; Uccelli A; Moretta L; Martini A; Traggiai E
    Arthritis Rheum; 2010 Sep; 62(9):2776-86. PubMed ID: 20496367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.